{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Wang Y"],"funding":["Natural Science Foundation of Zhejiang Province","National Natural Science Foundation of China"],"pagination":["e062096"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9486336"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(9)"],"pubmed_abstract":["<h4>Objectives</h4>To explore the outcomes of <i>Helicobacter pylori</i> infection treatments for naïve patients in the real-world settings.<h4>Design</h4>A retrospective observational study.<h4>Setting</h4>Single tertiary level academic hospital in China.<h4>Participants</h4>We identified patients initially receiving quadruple therapy for <i>H. pylori</i> infection from 2017 to 2020 in whom eradication was confirmed (n=23 470).<h4>Primary outcome</h4>Efficacy of different initial <i>H. pylori</i> infection treatments.<h4>Secondary outcome</h4>Results of urea breath test (UBT) after <i>H. pylori</i> eradication.<h4>Results</h4>Among 23 470 patients who received initial <i>H. pylori</i> treatment, 21 285 (90.7%) were treated with amoxicillin-based regimens. The median age of the patients de"],"journal":["BMJ open"],"pubmed_title":["Short-term outcomes and intermediate-term follow-up of <i>Helicobacter pylori</i> infection treatment for naive patients: a retrospective observational study."],"pmcid":["PMC9486336"],"funding_grant_id":["LY21H160023","81773065"],"pubmed_authors":["Li Y","Du Q","Xiang Y","Wang Y","Wu Y","Liao O","Ye J"],"additional_accession":[]},"is_claimable":false,"name":"Short-term outcomes and intermediate-term follow-up of <i>Helicobacter pylori</i> infection treatment for naive patients: a retrospective observational study.","description":"<h4>Objectives</h4>To explore the outcomes of <i>Helicobacter pylori</i> infection treatments for naïve patients in the real-world settings.<h4>Design</h4>A retrospective observational study.<h4>Setting</h4>Single tertiary level academic hospital in China.<h4>Participants</h4>We identified patients initially receiving quadruple therapy for <i>H. pylori</i> infection from 2017 to 2020 in whom eradication was confirmed (n=23 470).<h4>Primary outcome</h4>Efficacy of different initial <i>H. pylori</i> infection treatments.<h4>Secondary outcome</h4>Results of urea breath test (UBT) after <i>H. pylori</i> eradication.<h4>Results</h4>Among 23 470 patients who received initial <i>H. pylori</i> treatment, 21 285 (90.7%) were treated with amoxicillin-based regimens. The median age of the patients de","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2025-04-19T21:45:59.018Z","creation":"2025-04-19T21:45:59.018Z"},"accession":"S-EPMC9486336","cross_references":{"pubmed":["36115671"],"doi":["10.1136/bmjopen-2022-062096"]}}